Found: 11
Select item for more details and to access through your institution.
CU06‐1004 alleviates vascular hyperpermeability in a murine model of hereditary angioedema by protecting the endothelium.
- Published in:
- Allergy, 2023, v. 78, n. 5, p. 1333, doi. 10.1111/all.15674
- By:
- Publication type:
- Article
SALM4 regulates angiogenic functions in endothelial cells through VEGFR2 phosphorylation at Tyr1175.
- Published in:
- FASEB Journal, 2019, v. 33, n. 9, p. 9842, doi. 10.1096/fj.201802516RR
- By:
- Publication type:
- Article
A novel small molecule, CU05-1189, targeting the pleckstrin homology domain of PDK1 suppresses VEGF-mediated angiogenesis and tumor growth by blocking the Akt signaling pathway.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1275749
- By:
- Publication type:
- Article
Primaquine Diphosphate, a Known Antimalarial Drug, Blocks Vascular Leakage Acting Through Junction Stabilization.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.695009
- By:
- Publication type:
- Article
CU06-1004 Alleviates Experimental Colitis by Modulating Colonic Vessel Dysfunction.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.571266
- By:
- Publication type:
- Article
CU06-1004 enhances vascular integrity and improves cardiac remodeling by suppressing edema and inflammation in myocardial ischemia–reperfusion injury.
- Published in:
- Experimental & Molecular Medicine EMM, 2022, v. 54, n. 1, p. 23, doi. 10.1038/s12276-021-00720-w
- By:
- Publication type:
- Article
MicroRNA-148a/b-3p regulates angiogenesis by targeting neuropilin-1 in endothelial cells.
- Published in:
- Experimental & Molecular Medicine EMM, 2019, v. 51, n. 11, p. N.PAG, doi. 10.1038/s12276-019-0344-x
- By:
- Publication type:
- Article
Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model.
- Published in:
- Fluids & Barriers of the CNS, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12987-023-00410-x
- By:
- Publication type:
- Article
Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model.
- Published in:
- Fluids & Barriers of the CNS, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12987-023-00410-x
- By:
- Publication type:
- Article
Efficacy of CU06-1004 via regulation of inflammation and endothelial permeability in LPS-induced acute lung injury.
- Published in:
- Journal of Inflammation, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12950-023-00338-x
- By:
- Publication type:
- Article
CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment via Cytotoxic T Cells.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.620166
- By:
- Publication type:
- Article